Health professionals, their medical interventions and uncertainty : a study focusing on women at midlife by Griffiths, Frances et al.
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
This paper is made available online in accordance with 
publisher policies. Please scroll down to view the document 
itself. Please refer to the repository record for this item and our 
policy information available from the repository home page for 
further information.  
To see the final version of this paper please visit the publisher’s website. 
Access to the published version may require a subscription. 
 
Author(s): F. Griffiths, E. Green and G. Bendelow 
Article Title: Health professionals, their medical interventions and 
uncertainty: A study focusing on women at midlife 
Year of publication: 2006 
Link to published version: 
http://dx.doi.org/10.1016/j.socscimed.2005.07.027    
Publisher statement: None 
 
Health professionals, their medical interventions and uncertainty: a study focusing on 
women at midlife 
 
Authors: 
Frances Griffiths -  University of Warwick 
Eileen Green  - University of Teesside 
Gillian Bendelow  - University of Sussex 
 
Abstract 
Health professionals face a tension between focusing on the individual and attending to health 
issues for the population as a whole. This tension is intrinsic to medicine and gives rise to 
medical uncertainty, which here is explored through accounts of three medical interventions 
focused on women at midlife: breast screening, hormone replacement therapy and bone 
densitometry. The accounts come from interviews with UK health professionals using these 
medical interventions in their daily work. Drawing on the analysis of Fox (2002) we distinguish 
three aspects of medical uncertainty and explore each one of them in relation to one of the 
interventions. First is uncertainty about the balance between the individual and distributive ethic 
of medicine, explored in relation to breast screening. Second is the dilemma faced by health 
professionals when using medicial evidence generated through studies of populations and 
applying this to individuals. We explore this dilemma for hormone replacement therapy. Thirdly 
there is uncertainty because of the lack of a conceptual framework for understanding how new 
micro knowledge, such as human genetic information, can be combined with knowledge of other 
biological and social dimensions of health. The accounts from the bone denistometry clinic 
indicate the beginnings of an understanding of the need for such a framework, which would 
acknowledge complexity, recognising that factors from many different levels of analysis, from 
heredity through to social factors, interact with each other and influence the individual and their 
health. However, our analysis suggests biomedicine continues to be dominated by an 
individualised, context free, concept of health and health risk with individuals alone responsible 
for their own health and for the health of the population. This may continue to dominate how we 
perceive responsibilities for health until we establish a conceptual framework that recognises the 
complex interaction of many factors at macro and micro level affecting health. 
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Introduction 
Medical uncertainty, a term thought to be initiated by Parsons (1951), and developed further by 
Fox (1999, 2002) has become a key aspect in understandings of contemporary interactions 
between health professionals and patients (Gabe et al 2004) as modern society is increasingly 
characterised as one in which individuals seek to reduce anxiety and powerlessness by pursuing 
rational choices and no longer passively accepting their fate (Giddens 1991, Alaszweski and 
Harvey 2001). The rhetorical nature of such individual choice has however been problematised ( 
Lippman 1999, Alaszweski and Harvey 2001) as, certainly in the case of technological medical 
interventions, doctors remain the key decision–makers in their deployment. Foucault (Foucault, 
1976) has argued that medical power is maintained through the operationalisation of the medical 
discourse. Using data collected from an ESRC funded study {Griffiths, 2003 #411}, this paper 
examines issues of uncertainty and medical interventions for women in mid-life in order to 
contribute to understanding how medical power is currently being maintained through these 
discourses and the potential for change in the disourse of medical uncertainty. 
 
The study focuses on three medical interventions focused on women at midlife: breast screening 
with mammography, screening for risk of osteoporosis (brittle bones) using bone densitometry 
and hormone replacement therapy (HRT), used for the relief of symptoms of the menopause and, 
until recently, widely used for the prevention of osteoporosis. The medicalisation of women’s 
bodies at midlife, at least in part through the use of these technologies, has been debated over the 
past 20 or more years. It has long been argued that  HRT can be seen as a form of social control 
imposed on women to keep their pathological bodies under control and to conform to societal 
expectations which value women in terms of youth and beauty (Oakley 1984 Martin 1987 Greer  
Klein & Dumble, 1994). However, more recently it has also been argued that women engage 
with medicalisation (Denny 1996, Griffiths, 1999; Williams & Calnan, 1996) and may even see 
HRT as a lifestyle choice to help cope with the effects of ageing and to reinvent themselves 
(Fairhurst, 1998). Roberts  argues that sociological theory needs to allow for the possibility of 
HRT working to the benefit of some women (Roberts, 2002:). However, the literature has not 
examined the discourse used by health professionals about the medical interventions they use 
and about medical uncertainty, a missing element in understanding the dynamics of the power 
relationship between midlife women and health professionals. 
 
Screening forms part of what has become known a surveillance medicine (Armstrong, 1995) 
which, it is argued, has become a major part of health care. (Nettleton, 1996) has pointed to 
potential negative consequences of screening for women. For mammography screening this can 
include the anxiety engendered by false positive results and the false reassurance of false 
negatives (Gigerenzer, 2002). Medical interventions such as screening can produce specific 
measurements, the interpretation of which may be perceived as a threat to the individual 
(Lauritzen and Sachs, 2001). Although aware of the potential negative consequences of 
screening for women, Nettleton points to paradoxes embedded in prevention where the health of 
the community is the aim, commenting ‘all citizens have a right and a duty to maintain, 
contribute to and ensure… their health status’ (Nettleton, 1997). Women at midlife recognise this 
responsibility as one factor in their decision making about screening for osteoporosis (Griffiths 
& Green, 2003a). (Mant, 1994) has suggested that doctors, who are normally focused on 
diagnosis and treatment of individual patient’s illness, are willing to take on a role in screening 
aimed at the whole population, as they feel a responsibility for patients who develop a disease 
that they consider could have been prevented through screening, despite evidence questioning 
the usefulness of some screening. These commentaries on both women and health professional’s 
approach to screening alerts us to the uncertainty for individuals within any screening: how can 
we know that a particular individual was better off for being screened? Screening is based on 
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estimates of probability so we cannot know for certain. Gigerenzer (2002) in his commentary on 
breast cancer with mammography, suggests that many doctors over interpret the possible benefit 
of breast screening because they do not sufficiently understand the probability, and that this 
contributes to the perpetuation of an illusion of harm-free benefit for women. The medical 
profession are beginning to learn how communication about risk can be improved (Edwards, 
Elwyn , & Mulley, 2002). However, the uncertainty implicit in risk remains. Writing in the 
Lancet about the use of medical evidence in consultations Sullivan and MacNaughton (Sullivan 
& MacNaughton, 1996) talk of doctors taking an interpreted and individualized approach, in 
which the doctor acts ‘wisely in the face of inevitable uncertainty’ (page 941)  
 
The inevitable uncertainty in medicine, in particular in relation to technological interventions, is 
the focus of this paper. As we have discussed, this is an issue for those using the intervention, 
here the midlife women and those deploying it. We focus on health professional discourse on 
uncertainty, a missing element in the current literature. Other papers from the same project 
examine how doctors talk to women about uncertainty (Griffiths, Green, & Tsouroufli, 2005)and 
what women hear from their health professionals about uncertainty (Green, Thompson and 
Griffiths in preparation). Renée C Fox has developed the most extensive framework for 
understanding the different types of medical uncertainty (Fox, 2002). This paper uses her 
framework in the analysis of interviews with health professionals talking about the three medical 
interventions focused on women at midlife. Fox (ibid) suggests that medicine and its relationship 
with uncertainty is an indicator of more general social and cultural trends. This paper aims to 
explore the ‘social and cultural’ implications of the discourse of health professionals about 
medical uncertainty. 
 
The ideosyncratic and the generalising in medicine 
 
Rosenburg ((Rosenburg, 1998) explores the tension in medicine between a desire to attend 
primarily to the individual patient and a need to attend to the health issues for the population as a 
whole: 
 
‘The conflict between idiosyncrasy as opposed to the…generalising – tendency is central 
to medicine’s history… Although there is an essential tension between the two ways of 
understanding medicine, they are, in practice, mutually constitutive. Diseases must 
always manifest themselves in the bodies and minds of individual patients. And – 
reciprocally – a focus on the individual and the idiosyncratic leads the physisian towards 
the general and the schematic as he or she seeks to treat and predict. (page 349) 
 
This account from Rosenberg clarifies that the tension integral to medicine between the 
ideosyncratic and the generalising is here to stay. Medicine will always face the tension between 
giving priority to the needs of the individual patient and giving priority to population health 
needs. Medicine also faces tensions about what is good medical evidence, based on studies of 
populations or individual patients. These tensions are explored for mammography screening, 
HRT and bone densitometry. 
 
We chose to investigate these three interventions as they are focused on one stage in women’s 
lifecourse, and are often used by healthy women. This allows exploration of the issue of 
uncertainty in relation to medical interventions without needing to pay careful attention to other 
issues such as age, gender and also types of illness and suffering, particularly the vulnerability of 
those receiving a medical intervention. The three forms of intervention are interrelated through 
their use and side effects. Mammography is used for breast cancer screening. HRT was used for 
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the prevention of osteoporosis, the latter being detected through the use of bone densitometry. 
There is evidence that HRT use increases the incidence of breast cancer (Million Women Study 
Collaborators, 2003; Writing Group for the Women's Health Initiative Investigators, 2002).  
 
Drawing on the analysis of (Fox, 2002) we distinguish three aspects of medical uncertainty that 
arise from the tension beteen the ideosyncratic and the generalising in medicine. Firstly, there is 
uncertainty about the balance between the individual and distributive ethic of medicine. For 
example, what is the appropriate balance between attending to individual’s health needs and 
attending to health needs of a population and what benefits and disbenefits does attending to the 
one have for the other? For example, attending to population health needs may cause disruption 
for some individuals. Likewise, attending to individual needs may use resources that could have 
been used for the needs of the population. Secondly, there is the dilemma faced by health 
professionals when using medicial evidence generated through studies of populations, such as 
clinical trials and epidemiology, and applying this evidence to individual patients. For example, 
we know that smoking causes cancer but a doctor does not know if the patient sitting infront of 
them will get cancer or not. This Fox calls ‘epistemological uncertainty’ (ibid). Thirdly there is 
uncertainty because of a lack of a conceptual framework for our understanding. For example 
how can the new knowledge about the human genome (our genetic make up), be combined with 
knowledge about other biological and social dimensions of medicine and health to be of use to 
the practice of medicine? Medicine does not have a conceptual framework for linking up the 
different levels of understanding related to health from genes through physiology, psychology, 
family, community and society.  These three aspects of uncertainty will be explored below. 
Accounts of each of the health care interventions, breast screening using mammography, 
hormone replacement therapy and bone densitomety, will assist in exploring the three types of 
uncertainty. 
 
The study 
 
This paper considers data collected as part of an ESRC funded research project (Griffiths, Green, 
Bendelow, & Backett-Milburn, 2003) which was part of the Innovative Health Technology 
programme (Webster, 2004). The project, undertaken in the UK, involved interviews with 98 
women aged 45-64 years sampled from both community groups and health care sites, interviews 
with 58 health professionals sampled from both primary care and specialist health care sites and 
109 recordings of health care consultations (Griffiths, Green, Bendelow et al., 2003). This paper 
reports on semi-structured interviews with the health professionals working in specialist clinics 
sited in hospital outpatient facilities: a breast screening and follow up clinic, a bone clinic 
including bone densitometry and a HRT clinic which also sometimes included bone 
densitometry. Seven nurses, seven doctors and two radiographers were interviewed individually. 
 
At interview the health professionals were asked their views on health priorities for women at 
midlife in general, their own knowledge of all three medical interventions and how they 
discussed them with women in the clinic. The interviews did not ask about specific patients but 
about their clinical practice in general. This paper focuses on what they said about the 
technology with which they worked. 
 
Analysis of the project data was undertaken by the project team through a process of reading the 
data, identifying key themes, relating the themes to social science literature and then going back 
to the data. The theme of ‘medical uncertainty’ was identified as a strong theme across the data 
set at an early stage of analysis. Another paper (Griffiths, Green, & Tsouroufli, 2005) reports on 
how it was dealt with in health care consultations. For this paper the team undertook a 
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comparative analysis of each health professional’s account of the technology with which they 
worked. The analysis presented is based on the whole account from each interview, but for 
reasons of space is only illustrated with selected data. These health professionals provide what 
could be considered an ‘expert’ view of the medical interventions from within the health 
professions generally. Fox (2002) identifies that one uncertainty for the individual doctor (or 
nurse) is the impossibility of knowing all that is known related to medicine and health. The 
health professionals interviewed for this paper were likely to have a high degree of knowledge 
about the specific medical intervention with which they worked, and much more than those 
working in general medical or nursing practice, or lay individuals. 
 
The accounts of the use of the health technologies by the health professionals were analysed in 
relation to literature on medical uncertainty. This led to the alignment of the different 
interventions with the three types of medical uncertainty described in the previous section. This 
analysis is presented below. 
 
The individual and distributive ethic: the example of breast screening with mammography. 
 
Mammography is X-ray of the breast used to detect breast lumps that cannot be felt (screening) 
or to help with diagnosis when women feel a breast lump. This paper only considers its use for 
screening when the aim is to reduce the number of deaths from breast cancer in the population as 
a whole. Its use for screening follows a distributive ethic and in the UK the breast screening 
service is led by doctors (Cancer Research UK, 2004). However, these same doctors also 
undertake individual assessments of women asked to attend follow up clinics after screening. In 
these clinics the focus is on the individual so the individual ethic is to the fore. 
 
In the UK, breast screening with mammography was established following a report based 
evidence from epidemiology and clinical trails, that early detection and treatment would reduce 
the rate of early death from breast cancer (Forrest, 1986). Policy makers judge the effectiveness 
of breast screening in terms of its contribution to population health. An epidemiological study 
using data from 1990-1998 in England and Wales has shown that the total reduction in mortality 
from breast cancer for women aged 55-69 years was 21.3% compared to the predicted mortality 
based on the previous decades increasing mortality. Not all of this change in mortality rate can 
be attributed to the breast screening programme, although it is estimated that about one third of 
the reduction is a direct effect of screening (Quinn, 2004). The reduction in death rate by 
screening is only brought about through individuals attending and if necessary having treatment. 
This contrasts with other medical interventions where there is a biological aspect to the 
distributive ethic. For example, immunisation against an infectious disease provides protection 
for the individual that is immunised but also contributes to building the ‘herd immunity’: if 
sufficient people in a population are immunised, the infectious disease cannot easily spread 
through the population, so the non-immunised are also protected. With breast screening there is 
no biological effect beyond that of an individual’s contribution to the population mortality 
statistics. There may be non-biological effects such as women considering attendance at breast 
screening to be a social obligation, and women wanting to be a good role model for their children 
by attending (Griffiths, Green, Bendelow et al., 2003). 
 
The account of breast screening in the medical literature is reflected in the account given in the 
study, by an ‘expert’ among ‘experts’. This interviewee advises at national level on issues related 
to breast screening, oversees the local screening service and assesses women in the follow up 
clinic. 
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I think about screening as an intervention…..to improve the population’s well-being. And 
(pause) that, I think, is quite different to how other people perceive it….it’s about dealing 
with whole populations, for population benefit. Within that population, a small number of 
women…..get a real major benefit. Doctor 02 
 
This emphasises the distributive ethic improving population health. This doctor goes on to say: 
 
The vast majority has no benefit from it at all, apart from perhaps false reassurance. And 
some people have real disadvantage from it. Doctor 02 
 
The doctor thus acknowledges the individual ethic, concerned with the wellbeing of the 
individual including the disadvantages to individual women of attending screening which include 
anxiety about results (Green, Thompson, & Griffiths, 2002; Wadsworth & Green, 2003) and 
goes on to recognise that individual women attend screening  
 
as they are looking for personal benefit out of it. Doctor 02 
 
However, this ‘expert’ among ‘experts’ then re-asserts the intellectual understanding of the 
distributive ethic over the clinical individual benefit although acknowledges that his view of 
breast screening is perhaps different from how others see it. 
  
it is nice to find someone whom you are offering a personal benefit to, but that’s not the 
process from our—my point of view. Screening is about—screening, for me, is about 
reducing numbers of deaths in the whole population. Doctor 02 
 
The next account comes from a doctor who assists in running the local screening service and sees 
women in the follow up clinic. 
  
Mammography, of course, now it is that we strongly recommend it for everybody to 
have…I am totally convinced that it is helpful. And I see the people having benefit, both 
psychologically and otherwise….during my own practice I have seen the people 
diagnosed early, and they’ll live. Doctor 18 
 
This doctor seems convinced of the benefit of breast screening for the individual, thus giving 
more priority to the individual ethic. However, the doctor is clear that to achieve this, the 
population – ‘everybody’ - has to have breast screening, the distributive dimension. It is not 
completely clear whether the doctor uses the word ‘people’ to indicate a group or population of 
people or individual people. This slippage in the language between the distributive and 
individual effect of screening has a biological basis as mentioned above i.e. it is only through 
individuals having screening and treatment that the death rate comes down, unlike immunisation. 
However, it appears that the doctor is mostly drawing on clinical experience, seeing individual 
women live, rather than on population statistics. The doctor goes on to describe a further aspect 
of the impact of screening on the individual 
 
They—you can always come up with some statistical evidence to say that it is not 
effective…but generally, it does good… they (women) don’t feel guilty when they’re 
diagnosed—that they’re too late. Doctor 18 
 
This comment may be interpreted as women considering attendance at breast screening as a 
social obligation: they must attend in order to contribute to the improvement in population health 
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(Griffiths, Green, Bendelow et al., 2003){Nettleton, 1997 #218}. Although there may be many 
explanations for the guilt women feel on being diagnosed with breast cancer, the emphasis on 
self-surveillance of risky bodies{Lupton, 1999 #168} encouraged by the promotion of breast 
screening may be a significant factor. Thus the guilt, and moral issue, that the expert above talks 
about, may be created at least in part, by the distributive ethic of screening. As Fox points out 
‘handling and mediating the individual and collective dimensions of medicine’ (ibid page 245) 
creates tensions that are intellectual, clinical and moral. Each of these has been revealed in the 
accounts so far. 
 
Women attending a follow up after screening may see the Breast Care Specialist Nurse, 
particularly if they have positive tests indicating cancer. This contact with individuals in distress 
perhaps accounts for the emphasis by the Specialist Nurse on the stress and fear for individual 
women as well as the benefit of screening: 
 
I think screening... is always a big help for women….it gives them a reassurance, but it 
does stress them as well……… I think everyone dreads the results coming though….but I 
think you have to fight that fear really, you know, prevention’s better than waiting for 
something to develop.. Nurse 10 
 
Another Specialist Nurse also talks about the individual ethic,  
 
for those that find it a worrying time, I think we need to accept and respect their views 
and concerns 
but adds 
 
hopefully they do come forward into the screening programme; and they’re supported 
through that process. 
 
reflecting her very positive stance towards breast screening 
 
I would truly advocate screening to all other women …. We need to ensure that we 
profile screening in a very positive way Nurse 08 
 
Both Specialist Nurses describe the tension between the distributive ethic, screening as a good 
thing for population health, and the individual ethic including the anxiety and fear it can create. 
This latter aspect is seen as something that individuals can overcome. 
 
The final quote in this section is from a radiographer who only encounters individual women 
during the process of using the mammography technology and, apart from greetings and 
instructions, has very little dialogue with them. Their aim is a good technical result and the 
comfort of the women in the process. The radiographer said 
 
the breast screening service .. (is).. a very good thing…..whether the interval is two years 
or three years, again, research will show whether we are using the right screening 
interval…all the changes that we’ve made we have made on … scientific research. 
Radiographer 01 
 
The emphasis is on the distributive ethic, improving the health benefits for the population, and 
basing this on (population based) research. 
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There is variation in how the professionals or ‘experts’ understand, express and cope with the 
tension between the individual and distributive ethic of medicine. This seems to be partly 
influenced by the context and by how much contact each ‘expert’ has with individual women. 
Where their role is mostly orientated to the individual then the individual ethic of medicine 
dominates. Where their role is mostly orientated to the technology and screening process, the 
distributive ethic predominates. In most of the above accounts where the individual and 
distributive ethic were both mentioned, the account slid easily between the two, disguising the 
intrinsic tension. Only the ‘expert’ among ‘experts’ made the very clear distinction between the 
individual and distributive ethic and commented directly on the tensions this created, perhaps 
reflecting the difficulty for people of understanding and handling the tensions. 
 
Epistemological uncertainty: the example of hormone replacement therapy 
Fox suggests that the rise of the evidence based medicine movement in the 1990s ‘brought to the 
surface fundamental epistemological uncertainty about the nature of good clinical research, good 
clinical practice, and the relationship between them.’ (Fox, 2002). She suggests that the emphasis 
on ‘evidence’ based decisions has led to an oversimplification of the complexity of clinical 
decisions and a spurious claim to certainty. She refers to this issue as ‘epistemological 
uncertainty’ (Fox, 2002). Tanenbaum also identifies this issue and the importance given to the 
accuracy of risk prediction, which she refers to as ‘certain probabilities’ (Tanenbaum, 1994; 
Tannenbaum, Nasmith, & Mayo, 2003). Health professionals advise and treat individual patients, 
yet the evidence on which they base many decisions about health interventions is drawn from 
research with populations. For example, epidemiology and clinical trials may provide evidence 
for the need for the population to stop smoking in order to reduce the incidence of lung cancer, 
however it does not tell us which patient will get lung cancer (Willis, 1995). This tension 
between treating the individual patient and the nature of medical evidence has been an 
undercurrent in debate about the use of evidence in practice over the last decade or more. 
Tanenbaum (Tanenbaum, 1994), in discussing research such as clinical trials, identifies the 
politics of this type of research as the ‘medical legitimisation of practice guidelines and the 
relative disempowerment of practising physicians’ (more so with outcomes research than with 
bench science she contends) and ‘additional interpretive work for practising physicians’. An 
indication of this additional interpretive work is given by (Glasziou & Irwig, 1995) in their 
guidance on how to interpret evidence for the individual patient based on data from clinical trials 
of intervention effectiveness, prediction of risk for the patient and the patients values. However, 
doctors find this difficult (Gigerenzer, 2002) and even where the evidence has been developed 
into guidelines, doctors find it difficult to apply the guidelines to many individual patients 
(Summerskill, William, & Pope, 2002). 
 
HRT has been the focus of large epidemiological studies and clinical trials, the most recent of 
which reported in 2002/3. The results of a US clinical trials confirmed a higher incidence of 
breast cancer among women who have taken HRT long term (Writing Group for the Women's 
Health Initiative Investigators, 2002). These results were supported by a UK epidemiological 
study (Million Women Study Collaborators, 2003). Until this new research, HRT was 
recommended in medical literature for the relief of menopausal symptoms, the prevention of 
osteoporosis and as an intervention to be considered for the prevention of cardio-vascular disease 
such as heart attacks. Its use for prevention entailed the women taking HRT long term. Ballard 
demonstrated that although most women were using it primarily for symptom relief, their 
awareness of risk of osteoporosis was one explanation used by the women for remaining on HRT 
for longer (Ballard, 2002a; Ballard, 2002b). Until the publication of the 2002/3 research results, 
HRT was strongly advocated for the prevention of osteoporosis where a woman was considered 
to be at high risk. However, guidelines issued to health professionals about the length of use of 
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HRT and how often its use should be reviewed have now been changed (Boukes, Groeneveld, & 
Assendelft, 2003; Committee on Safety of Medicines and Medicines and Healthcare Products 
Regulatory Agency, 2003). 
 
The accounts from ‘experts’ about HRT were collected prior to the publication of the new 
research results in 2002. The senior doctor at the clinic seems to be an advocate of HRT 
 
…although there is obviously an awful lot we still don’t understand ……I suspect that it 
would actually bring major benefits to several times as many people as are currently taking 
it…Doctor 11 
 
He goes on to describe the approach he takes in the HRT clinic 
 
………. we go through all their (women attending the clinic) risk factors for their bones 
and…their risk factors for all the other things that hormone replacement therapy could 
benefit …. and their risk factors for thrombosis and .. breast cancer. And we see what we’ve 
got on each side of the scales. And we weigh it up. So the decision to take HRT is based on 
an understanding of what the benefits are going to be and what the risks are going to be. 
Doctor 11 
 
The account seems to imply that the evidence on risk can apply directly to individual women to 
provide some form of prediction. This doctor goes on to describe how he perceives the 
understanding of risk of the women attending the clinic. 
 
….with HRT they (women attending the clinic) usually know about the breast cancer risk…. 
they’re sometimes surprised to know that although it’s a very small increase, it’s an 
increased risk which we believe starts on day one, because in the past people used to believe 
this risk comes along at five years or this risk comes along at ten years. And so a lot of 
women have developed a view that they would be completely safe up until the five years. 
And then suddenly they will be at risk. So, so sometimes they’re, they’re a little bit alarmed 
about that. They’re not usually alarmed at the size of the risk, particularly, when we put in 
context with other breast cancer risk factors. That it’s often a smaller level of risk than they 
thought it was. Doctor 11 
 
The account does not mention the dilemma of applying risk based on population evidence to the 
individual but focuses entirely on misunderstanding and understanding the time-scale and size of 
the risk. Analysis of consultations from this clinic demonstrated that the emphasis given to 
weighing up risk and benefit led to the weaving of an account of HRT that implied certainty of 
outcome (Griffiths, Green, & Tsouroufli, 2005, In Press). A doctor, who is in training as a 
specialist at the clinic, also talks about weighing up risk and benefit 
 
.. you have to have the balance between…quality of life and between the risk that you are 
taking with HRT…which is very small. And on balance...in outcomes between people who 
are not taking HRT and people who are taking HRT, the people who are taking HRT would 
come ...with a quality of life much, much better, plus protection for osteoporosis. Doctor 10 
 
It is not clear from the interview whether the doctor is using ‘people’ to mean a population of 
individuals or the individuals he sees in the clinic, a slippage of language that was identified in 
accounts of breast screening above.  The doctor goes on to say 
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And you have to put this balance to the patient. And they need to choose. Um, and they need 
to take the choice between...it’s all about risks and benefits. Doctor 10 
 
This doctor seems to be providing a similar account to that of the senior doctor in the clinic 
(Doctor 11). In their interviews these two doctors provide no indication of their understanding of 
epistemological uncertainty and the dilemma this creates. Other data from the study indicates 
that in other contexts this epistemological uncertainty may be explicitly recognised by health 
professionals (Griffiths, Green, & Tsouroufli, 2005, In Press). The ‘experts’ talking here are 
considered ‘experts’ by other doctors (or ‘expert’ in training). Their discourse is influential 
within their locality and reinforced through mechanisms such as clinical letters written to doctors 
about individual patients, and up-date lectures given for local health professionals. Their 
operationalisation of the medical discourse is likely to reinforce the pressure on other health 
professionals particularly those not ‘expert’ in this particular medical intervention, to take a 
similar approach. 
 
A conceptual framework for uncertainty: the example of bone densitometry 
In her analysis of medical uncertainty, Fox (2002) identifies the Human Genome Project to 
illustrate another form of uncertainty. She argues that the Human Genome Project provides 
knowledge, which is highly reductionist yet despite its many claims, ‘there is as yet no 
conceptual framework within which this kind of micro-knowledge can be synthesised, 
consolidated and made pertinent to the organismic, pathophysiolological level of medicine’. The 
writing of (Birke, 2003) suggest that the social and cultural levels, need also to be part of the 
missing conceptual framework. She argues that there is interaction of the biological, with social 
and cultural forces in a process of co-evolution that goes beyond the surface of the body to inside 
the body. 
 
… We need to find ways of acknowledging that internal biology is a factor in our 
becoming, while at the same time recognising that there are many other factors too….. It 
is not biology that we need to reject wholesale; rather, it is simplistic assumptions that 
certain biological processes are primary, and that it’s the biology of the isolated 
individual that matters’ (page 44). 
 
Biological systems can be conceived of as being nested within and interacting with social 
systems (Harvey & Reed, 1994) resulting in co-evolution (Byrne, 1998). Bone densitometry and 
accounts of this intervention from ‘experts’ will help us explore what Fox (2002) means by the 
missing conceptual framework and how medicine is perhaps groping towards filling this gap. 
 
Bone densitometry, using a dual energy X-ray absorptiometry (DEXA scan), measures an 
individual’s bone density and compares it with measurements from a ‘normal population’ (i.e. 
measurements of the bone densities of individuals sampled from the general population). If an 
individual’s bone density is low relative to ‘normal’ the individual is considered at risk of 
osteoporosis in the future, as the density of bone decreases as people age. A very low 
measurement indicates osteoporosis is already present. The significance to the individual is that 
when bone has become thin (osteoporotic) it may fracture easily and the fracture causes pain and 
disability (Wilkin, Devendra, Dequeker, & Luyten, 2001). 
 
The two doctors interviewed in the bone densitomety clinic were specialists in osteoporosis. The 
interviews focused on the use of DEXA scanning for people at risk of oseoporosis rather those 
considered to have a current diagnosis of osteoporosis. 
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In describing bone densitometry one of the doctors said 
 
No test in medicine is perfect.  What bone densitometry has been used as, is a definition.  
Like most things in life when you study it all disappears into the detail but people want 
simple answers. Doctor 28 
 
There seems to be an acknowledgment of some uncertainty about the result produced by bone 
densitometry. This may in part be the ‘epistemological uncertainty’ as discussed above, as the 
notion of risk is applied to individuals. 
 
 
The doctor goes on to say 
 
 it’s a very good test for categorising people as to their future err fracture risk Doctor 28 
 
The use of the words ‘categorising’ and ‘risk’ in the same phrase gives a taste of the issues the 
doctor is struggling with. We will first follow up on ‘risk’. Epidemiology has demonstrated that 
osteoporosis is more common in women as they get older, who have a family history of 
osteoporosis, a low body mass index (ratio weight:height), smoke, take little weight bearing 
exercise, take little calcium in their diet or have certain other health problems or treatments 
known to affect bone density (Royal College of Physicians and Bone and Teeth Society of Great 
Britain, 2001). These risk factors can be used to decide if a woman is ‘at risk’ and so considered 
a ‘case’ where bone densitometry should be used to clarify her classification as ‘at risk’ (ibid). 
The different risk factors do not combine in any straightforward way to predict risk of 
osteoporosis but are seen as ‘important information in the overall decision making’(Wilkin, 
Devendra, Dequeker et al., 2001). It is also interesting to note that these risk factors relate to 
biological, psychological, social and cultural aspects of an individual’s life. 
 
Returning to the words of the doctor above, the use of the word ‘categorising’ may indicate the 
specialist is seeing the individual as a particular case rather than as a member of a population. In 
research terms ‘cases’ may be categorised into groups where the ‘cases’ are similar and 
characteristics of the whole ‘case’ is used for this categorisation. Populations are usually 
described in terms of variables, which are markers of only certain aspects of each individual 
(Byrne, 2002). What can be confusing with the example of bone densitometry is that the 
interpretation of a particular bone densitometry result is based on how it compares with bone 
density measurements (a variable) of the population. The result gives 
 
a number to the degree of osteoporosis a person has.  So it does enable people to see 
where they are in the spectrum of other patients results Doctor 27 
 
So the interpretation of the bone density is in relation to a population. However, the result or 
‘number’ as the above doctor calls it, is then viewed as applying to the particular women. The 
word ‘categorise’ is used to clarify this. 
 
So bone mineral density is excellent.  As a diagnostic tool or at least a categorising tool to 
say whether people are likely to benefit or not. Doctor 28 
 
The individual ‘case’ is categorised into either a group likely to benefit from treatment or a group 
not likely to benefit. In 1992 DEXA scanning was recommended for use for case-finding (rather 
than population screening) in the UK (School of Public Health, 1992). A recent review of 
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clinical guidelines for the detection and prevention of osteoporosis says bone density 
measurement using a DEXA scan, can predict future fracture ‘with high specificity, but low 
sensitivity’ so recommends ‘the use of this test in the context of a case-finding strategy, rather 
than for population screening’(Royal College of Physicians and Bone and Teeth Society of Great 
Britain, 2001). 
 
The doctor goes on to expand on the case finding approach for osteoporosis. When deciding 
whether to undertake bone densitometry other characteristics of each individual ‘case’ are taken 
into account  
  
If there’s err a couple of fractures, fairly non, a-traumatic, just the odd trip or whatever 
and ...if there’s a strong family history on the female side of osteoporosis then ‘yes’ (do 
bone densitometry). Doctor 28 
 
There are clues here of the conceptual framework Fox (2002) sees as missing from medicine. 
The specialists are describing ‘cases’ using a constellation of factors. In the interviews the 
doctors also mention ‘lifestyle’ ‘medication’ (Doctor 27) and ‘age’ (Doctor 28) as well as 
heredity. Note again, as with the risk factors discussed above the specialists are talking about 
factors related to many aspects of life, not just the biological. However, the doctors give few 
indications of how these factors fit together. 
 
There is some acknowledgement of the complexity of the interactions between factors, for 
example the changing importance of low bone density in relation to rate of fractures: 
 
osteoporosis is a disease which increases (in) frequency with age and certainly fractures 
increase much, very much more rapidly because of the falling over contribution increases 
much greater later on. Doctor 28 
(older people fall over more as they age which contributes to the increase in rate of 
fracture with age) 
 
These accounts from bone clinic specialists seem to be groping towards an understanding of the 
missing conceptual framework (Fox 2002) for linking the genetic, the pathophysiological, the 
psychological, the social and the technological in medicine. The doctors indicate some ways in 
which factors from different levels of analysis interact with each other, but this is limited. Their 
accounts demonstrate the uncertainty of medicine as to how factors from different levels of 
analysis can be synthesised to develop an understanding pertinent to the individual ‘case’. 
Understanding the interaction of many factors for the individual woman is what McWinney 
refers to as the ‘science of particulars’ (McWhinney, 1989) and suggests medicine needs to 
develop research methods that give attention to the particular. This would require a conceptual 
framework that can synthesise knowledge from multiple levels of analysis (Fox 2002) and 
understand how factors interact and co-evolve. Interestingly, one of the specialists points out the 
use of bone densitometry as 
 
a tool to guide and influence people to appropriate management decisions about them, 
lifestyle or medication changes they’re going to undertake. Doctor 27 
 
thus acknowledging the bone densitometry result as more than a neutral number, but something 
that interacts with the individual women, influencing their decisions (Griffiths & Green, 2003b) 
and perhaps influencing their biology (Birke, 2003) 
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Before we leave the ‘experts’ in the bone clinic, we note that the account of bone densitometry 
from the specialist nurses were similar to that of the radiographer in the breast assessment clinic. 
They talked in terms of a good technological result and the comfort of the patients 
  
I think it’s a very good measurement, I particularly like the.. pixie scanner….for some 
people it’s a long time ….to lay…twenty minutes still, particularly if they’ve got other 
problems. Nurse 14 
 
I was interested on going on the bone density scanner when they were first setting it up ‘cos 
they needed volunteers to ... see if they could get a range…I can tell the patients I’ve had 
done myself and I know exactly what’s it’s about. Nurse 13. 
 
Conclusion 
This paper has explored three aspects of uncertainty in relation to three different medical 
interventions. At interview, uncertainty was not discussed explicitly by the health professionals 
or ‘experts’ however, their accounts reveal exactly the kinds of issues that Fox outlines: 
 
because medicine is so integrally associated with the most profound questions about our 
individual and collective origins and identity, our sense of purpose and meaning, our 
shared human condition and our ultimate mortality, its relationship to uncertainty is also 
an indicator of how sure and unsure we are of where we have come from and where we 
are going, societally and culturally, as we enter the new millennium (Fox, 2002 page 
250). 
 
For breast screening we described the tension between the benefits for individuals and for the 
population as a whole. For HRT, we described the tension generated by using evidence from 
populations and applying it to the individual. With the exception of the national ‘expert’ on 
breast screening, for both breast screening and HRT, the benefit or risk of the intervention for the 
individual was the main thrust of the health professional’s accounts. Through this focus on the 
individual, health professionals reinforce the idea that individuals are responsible for their own 
health. They advise individuals to act to reduce their own risk. However, these accounts from the 
‘experts’ also suggest that there is an agenda beyond the individual’s own health. There is an 
implication that individuals may be responsible not only for their own health but also for the 
health of the population. In other words, by reducing their own health risks, they contribute to a 
reduction in population risk and ultimately population measures of morbidity and mortality. Thus 
the accounts from the ‘experts’ working with breast screening and HRT illustrate a lack of clarity 
in the medical discourse about uncertainty related to what Fox describes as our ‘individual and 
collective origins and identity’ (ibid), and the tensions this creates. This lack of clarity seems to 
allow the medical discourse to ignore the multiple influences on health including legal, social, 
economic, cultural and household factors (Blaxter, 2003; Moss, 2002) and focus only on what 
individuals should do to reduce health risks for themselves and for the wider population. 
 
The specialists in the bone densitometry clinic were struggling to express a different uncertainty 
in medicine. Through understanding each woman as an individual ‘case’ they were beginning to 
indicate that there were multiple influences on health, from heredity through to social factors. 
The uncertainty was because of their lack of conceptual framework for bringing all this together. 
Some areas of medicine such as general practice and disciplines related to medicine such as 
medical ethics, have started to develop such conceptual frameworks (Gorovitz & MacIntyre, 
1976; Griffiths, 2002). Such frameworks acknowledge complexity, recognising that factors from 
many different levels of analysis may influence the individual and that these factors also interact 
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with each other and with the individual. Through this interaction there is co-evolution. For 
example, as Birke (2003) suggests, the biological and the social both change as a result of their 
interaction. Without an overarching conceptual framework medicine has been unable to make the 
most of this understanding. Fox cites how insights from the Human Genome Project may 
precipitate medicine into developing a conceptual framework so that ‘this kind of micro-
knowledge can be synthesised, consolidated and made pertinent’ (Fox, 2002).  
 
Discourses shape how we see the world and the biomedical discourse is a powerful one. 
Individualised, context free, concepts of health and health risk could continue to dominate how 
we perceive responsibilities for health well into the 21st century, if more sophisticated concepts 
are not developed. Whereas an individual undoubtedly may take some responsibility for their 
own health, this forms only one contribution to health improvement at both micro and macro-
levels. Many disciplines including biological sciences, behavioural sciences and the social 
sciences have contributed to understanding the many different influences on health and how 
these have their effects (Blaxter, 2003; Moss, 2002). This work has demonstrated that health can 
only be improved through intervening at macro and micro-levels. These diverse disciplines are 
also developing conceptual frameworks that have a great deal in common with each other and 
that begin to make sense of how the many different influences on health fit together (see e.g. 
(Byrne, 1998; Holt, 2004; Sweeney & Griffiths, 2003). These may provide what Fox (2002) 
suggests is needed, a framework that allows us to understand how ‘micro-knowledge’, the detail 
about how biological or social processes fit together and how this micro level influences and is 
influenced by the more macro-levels. However, these conceptual frameworks are currently not 
well known within medicine. Ironically, it may not be until the Human Genome Project, a 
powerful influence within biomedicine, realises its need for this conceptual framework that it 
becomes adopted by medicine as its own. 
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